Request Demo
Last update 01 Jul 2025
Tianjin Xinchen Taifeier Pharmaceutical Technology Co., Ltd.
Private Company | Subsidiary Company|2013|Tianjin Shi, China
Private Company | Subsidiary Company|2013|Tianjin Shi, China
Last update 01 Jul 2025
Overview
Related
NCT03691818
A Phase 2, Multicenter, Double-blind and Placebo and Active Control Study to Evaluate the Initial Efficacy and Safety of X0002 Spray in Treatment of Subjects With Osteoarthritis of the Knee
CTR20161001
比较盐酸布洛胺喷雾剂与布洛芬乳膏剂单次外用给药在健康受试者中的药代动力学特征的Ⅰ期研究
[Translation] Phase I study comparing the pharmacokinetic characteristics of a single topical administration of ibuprofen hydrochloride spray and ibuprofen cream in healthy subjects
NCT02794740
Study of X0002 Following Escalating Single and Multiple Doses Administered as Topical Application in Healthy Volunteers
100 Clinical Results associated with Tianjin Xinchen Taifeier Pharmaceutical Technology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Tianjin Xinchen Taifeier Pharmaceutical Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Tianjin Xinchen Taifeier Pharmaceutical Technology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 10 Jul 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free